Research Article

Hematological Inflammatory Markers in Patients with Clinically Confirmed Familial Hypercholesterolemia

Table 4

Relationship of cholesterol, LDL-C, and inflammatory markers.

GroupPLRNLRRPR
β (95% CI) valueβ (95% CI) valueβ (95% CI) value

CholesterolFHPossible0.004 (0.002, 0.007)<0.0010.000 (-0.001, 0.002)0.606-0.00002 (-0.00003, -0.00001)0.001
Definite and probable0.001 (-0.003, 0.004)0.765-0.00 (-0.002, 0.001)0.768-0.00001 (-0.00003, 0.00002)0.734
Total0.003 (0.001, 0.005)<0.0010.0002 (-0.001, 0.001)0.760-0.00001 (-0.00002, -0.000001)0.029
Non-FH0.001 (-0.00, 0.001)0.078-0.003 (-0.004, -0.001)0.001-0.00001 (-0.00004, 0.00003)0.731
Total0.003 (0.002, 0.005)<0.001-0.0001 (-0.001, 0.001)0.735-0.00001 (-0.00002, -0.000001)0.028

LDL-CFHPossible-0.00003 (-0.00004, -0.00001)0.0010.0005 (-0.001, 0.003)0.6090.005 (0.002, 0.008)0.002
Definite and probable-0.00001 (-0.00004, 0.00003)0.668-0.0003 (-0.002, 0.001)0.7360.0007 (-0.004, 0.006)0.787
Total0.0038 (0.0014, 0.0063)0.0020.0002 (-0.001, 0.002)0.790-0.00001 (-0.00003, -0.000001)0.035
Non-FH0.0006 (-0.0004, 0.0017)0.244-0.004 (-0.007, -0.002)0.001-0.000004 (-0.00005, 0.00006)0.897
Total0.004 (0.002, 0.006)<0.001-0.0002 (-0.001, 0.001)0.743-0.00002 (-0.00003, 0.00)0.050

Data are shown as β (95% CI). Linear random intercept model was used.